Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Author: evafenyvesi

March 9, 2026 CD derivatives / Drug delivery / Pharma applications

Oral Treatment of Obesity by GLP-1 and Its Analogs

Obesity is a multifaceted disease that significantly increases the risk of various chronic conditions. GLP-1R (co)-agonists first emerged as therapeutics

Continue reading

March 6, 2026 Drug delivery / Pharma applications / Uncategorized

Special issue: Advanced Polymeric Biomaterials for Drug Delivery Applications

 The present Special Issue in Polymers welcomes contributions in the form of original research articles, preclinical investigations, or review articles

Continue reading

March 5, 2026 CD derivatives / Pharma applications / Supramolecular systems

On-off switch of cellular migration using granular hydrogels containing beta-CD and adamantane

Cell migration plays a crucial role in the dynamic processes that guide tissue development, regeneration, and repair; yet, developing cell

Continue reading

March 3, 2026 CD derivatives / Non-pharma applications / Pharma applications

delta-Cyclodextrin is commercially available at Biosynth

δ‑Cyclodextrin (δ‑CD or delta-CD) is a unique, novel nine-membered cyclodextrin with a larger internal cavity than α-, β-, or γ-cyclodextrins,

Continue reading

March 2, 2026 CD as API / Pharma applications

Beren Therapeutics’Adrabetadex Received FDA Acceptance for infantile-onset Niemann Pick Disease

Beren Therapeutics Announced FDA Acceptance of its New Drug Application for Adrabetadex in Infantile-Onset Niemann-Pick Disease Type C. Beren Therapeutics

Continue reading

February 27, 2026 Drug delivery / Pharma applications

5th International Conference Integrative Chemistry, Biology & Translational Medicine

The conference will be held on 25-27 June 2026 in Debrecen. The journey of ICBTM began in 2019 with the

Continue reading

February 24, 2026 Non-pharma applications / Other industrial use

Amorphous Red Phosphorus: Host–Guest Assembly with Cyclodextrin

Amorphous red phosphorus (ARP) has recently been identified as a zig-zag ladder polymer, yet its function beyond a low-cost phosphorus

Continue reading

February 23, 2026 CD as API / Pharma applications

The mechanism of ototoxicity studied by using HPBCD

The cochlea is the sensory organ responsible for hearing. Central to its sensory functions is the organ of Corti, a

Continue reading

February 23, 2026 Food / Non-pharma applications

Debittering and Masking Soy Peptides for Oral Consumption and Immune-Boosting Function

Soy peptides (SPs) have been extensively studied with an emphasis on their immune-boosting effects and production-associated bitterness. This associated bitterness

Continue reading

February 20, 2026 Events

Symposium on Biodegradable Implants

The Materials Science and Engineering (MSE) Congress 2026 will be held from September 29 to October 1, 2026, in Darmstadt, Germany, as a

Continue reading

Posts pagination

«Previous Posts 1 2 3 4 5 … 118 Next Posts»

Recent Posts

  • Cyclodextrin Produced In situ: Rethinking Oat Milk Design for Better Performance
  • Structural diversity of cyclodextrin metal-organic frameworks enables their diverse applications
  • Exploring Cyclodextrin-Based MOFs for Drug Delivery: Synthesis, Applications, and Future Perspectives
  • Sugammadex analog water soluble BCD polymer for peptide complexes
  • 2 nd International Conference on Biomedical Science and Engineering

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (26)
  • Analysis (64)
  • CD as API (343)
  • CD derivatives (404)
  • Cosmetics and toilettry (49)
  • Diagnosis (12)
  • Drug delivery (786)
  • E-ducation (63)
  • Environmental (133)
  • Events (233)
  • Food (221)
  • Gene delivery (20)
  • Household products (4)
  • Household products (1)
  • In Hungarian (4)
  • Life sciences (42)
  • Non-pharma applications (396)
  • Other industrial use (104)
  • Pharma applications (1,173)
  • Supramolecular systems (40)
  • Uncategorized (144)

Top Posts

  • Cyclodextrin Produced In situ: Rethinking Oat Milk Design for Better Performance
  • Structural diversity of cyclodextrin metal-organic frameworks enables their diverse applications
  • Cyclodextrin-based formulations for pediatric patients: pharmaceutical prospectives and toxicological evaluation
  • Lanosterol eye drops for cataract treatment
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies
  • FDA Grants Approval to HPBCD-Enhanced Biologic: A 'Super-Originator' Formulation
  • Antiepileptic drug with betadex sulfobutyl ether sodium, Fycompa® injection approved in Japan
  • "Advances in Functional Materials" International Conference, 2021
  • Alterations in Proteostasis Mechanisms in Niemann–Pick Type C Disease
  • Aequus and reVision to Collaborate on Stargardt Disease Program using SBECD as active

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 3,791 other subscribers

Loading Comments...